Nayanta Sodha

Nayanta Sodha

UNVERIFIED PROFILE

Are you Nayanta Sodha?   Register this Author

Register author
Nayanta Sodha

Nayanta Sodha

Publications by authors named "Nayanta Sodha"

Are you Nayanta Sodha?   Register this Author

12Publications

237Reads

42Profile Views

Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.

Cancer Epidemiol Biomarkers Prev 2009 Jul 30;18(7):2123-31. Epub 2009 Jun 30.

Genetic Medicine, University of Manchester, Manchester Academic Health Science Center, Central Manchester University Hospitals NHS Foundation Trust, St Mary's Hospital, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-09-0138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869031PMC
July 2009

CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?

Nat Rev Cancer 2007 Dec;7(12):925-36

Cancer Research UK Centre for Cancer Therapeutics, Institute of Cancer Research, Haddow Laboratories, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc2251DOI Listing
December 2007

p53 therapy in a patient with Li-Fraumeni syndrome.

Mol Cancer Ther 2007 May 4;6(5):1478-82. Epub 2007 May 4.

Mary Crowley Medical Research Center, Baylor University Medical Center, 60th Floor, 1717 Main Street, Dallas, TX 75201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-0125DOI Listing
May 2007

BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trial.

Cancer Lett 2007 Mar 14;247(2):259-65. Epub 2006 Jun 14.

Translational Cancer Genetics Team, Section of Cancer Genetics, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2006.05.003DOI Listing
March 2007

Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation.

Cancer Res 2006 Sep;66(18):8966-70

Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-06-1990DOI Listing
September 2006

Analysis of familial male breast cancer for germline mutations in CHEK2.

Cancer Lett 2004 Nov;215(2):187-9

Royal Marsden NHS Trust, Downs Road, Sutton SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2004.07.002DOI Listing
November 2004

A robust method for detecting CHK2/RAD53 mutations in genomic DNA.

Hum Mutat 2002 Feb;19(2):173-7

Royal Marsden NHS Trust, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.10031DOI Listing
February 2002